ATCC announces award from national institute of allergy and infectious diseases to support its preclinical services for biopharmaceutical product development Post author: Post published:November 13, 2023 Post category:uncategorized ATCC today announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract. You Might Also Like Semen microbiota might play a crucial role in influencing male fertility January 18, 2024 Noninvasive diagnostic tool for identification of NASH by visualizing hepatic steatosis and inflammation January 26, 2024 HPV infections increase prostate cancer risk by 2.3 times, study finds December 18, 2023
Noninvasive diagnostic tool for identification of NASH by visualizing hepatic steatosis and inflammation January 26, 2024